STALEVO 20050200 MG

Pays: Israël

Langue: anglais

Source: Ministry of Health

Achète-le

Ingrédients actifs:

CARBIDOPA AS MONOHYDRATE; ENTACAPONE; LEVODOPA

Disponible depuis:

INOVAMED PHARMA LTD, ISRAEL

Code ATC:

N04BA02

forme pharmaceutique:

FILM COATED TABLETS

Composition:

LEVODOPA 200 MG; ENTACAPONE 200 MG; CARBIDOPA AS MONOHYDRATE 50 MG

Mode d'administration:

PER OS

Type d'ordonnance:

Required

Fabriqué par:

ORION CORPORATION ORION PHARMA,FINLAND

Domaine thérapeutique:

LEVODOPA AND DECARBOXYLASE INHIBITOR

indications thérapeutiques:

Treatment of patients with Parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (DDC) inhibitor treatment.

Date de l'autorisation:

2016-07-24

Notice patient

                                STAL CTAB PL SH 290920
STAL CTAB PL SH 290920
PATIENT PACKAGE INSERT
IN ACCORDANCE WITH THE
PHARMACISTS’ REGULATIONS
)PREPARATIONS( – 1986
THE MEDICINE IS DISPENSED WITH A
DOCTOR’S PRESCRIPTION ONLY
STALEVO
®
50/12.5/200 MG
Film-coated tablets
STALEVO
®
75/18.75/200 MG
Film-coated tablets
STALEVO
®
100/25/200 MG
Film-coated tablets
STALEVO
®
125/31.25/200 MG
Film-coated tablets
STALEVO
®
150/37.5/200 MG
Film-coated tablets
STALEVO
®
200/50/200 MG
Film-coated tablets
ACTIVE INGREDIENTS
Stalevo 50/12.5/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
50/12.5/200 mg
Stalevo 75/18.75/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
75/18.75/200 mg
Stalevo 100/25/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
100/25/200 mg
Stalevo 125/31.25/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
125/31.25/200 mg
Stalevo 150/37.5/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
150/37.5/200 mg
Stalevo 200/50/200 mg
Each
tablet
contains
levodopa/
carbidopa/entacapone
200/50/200 mg
INACTIVE INGREDIENTS
See section 6 ‘Further Information’ and
section 2 ‘Before using the medicine’
in section ‘Important information
about some of the ingredients of the
medicine’.
READ THE LEAFLET CAREFULLY IN ITS
ENTIRETY BEFORE USING THE MEDICINE.
This leaflet contains concise information
about the medicine. If you have further
questions, refer to the doctor or
pharmacist.
This medicine has been prescribed
to treat your ailment. Do not pass it
on to others. It may harm them even
if it seems to you that their ailment is
similar.
1. WHAT
IS
THE
MEDICINE
INTENDED FOR?
For treatment of Parkinson’s disease.
THERAPEUTIC GROUP: Anti-Parkinson
medicines, dopa and dopa derivatives.
Stalevo contains 3 active ingredients
)levodopa, carbidopa and entacapone(
in one film-coated tablet. Parkinson’s
disease is caused by low brain levels
of a substance called dopamine.
Levodopa
increases
the
amount
of dopamine, thereby reducing the
symptoms of Parkinson’s disease.
Carbidopa and enta
                                
                                Lire le document complet
                                
                            

Résumé des caractéristiques du produit

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Lire le document complet
                                
                            

Documents dans d'autres langues

Notice patient Notice patient arabe 02-11-2020
Notice patient Notice patient hébreu 02-11-2020

Afficher l'historique des documents